Cytarabine Injection BP 100mg/1ml Single Use Vial

You can get Cytarabine Injection BP from us as a Cytarabine Injection BP 100mg/1ml single use vial, supplied under our TOROCYT-100 brand. Each milliliter holds cytarabine 100 mg in water for injection and nothing else. The carton states that it contains no antibacterial preservatives, so one vial serves one patient and whatever is left over is discarded. It sits in our oncology vials alongside the rest of the cytotoxic range.

Before you plan a channel for it, read the warning printed on the carton. This product is to be supplied against demand from a cancer hospital or institution, and against the prescription of a cancer specialist only. That line is not a formality. It decides who you can sell to, and it rules out ordinary retail pharmacy distribution, so build your route to market around hospitals and oncology institutions from the start.

Storage is simple but narrow. Keep it below 25°C and out of light. Do not use a vial if you can see particles in the solution, which is the first thing your pharmacy should check against the light before drawing it.

Cytarabine Injection BP Uses

Cytarabine is an antimetabolite, and approved labeling for the molecule covers leukemia rather than solid tumors:

• Induction and maintenance of remission in acute myeloid leukemia, in adults and children.
• Acute lymphocytic leukemia.
• Chronic myeloid leukemia in blast phase.
• Childhood non Hodgkin lymphoma, as part of combination regimens.

It is almost always given in combination rather than alone, and it is not active by mouth, which is why the injection exists at all. The carton on this pack is labeled for intravenous injection, and the route always follows the label of the product in hand. If your range already carries gemcitabine 1 gm, the two sit in the same antimetabolite family, so your existing oncology accounts are usually the same accounts for this one.

Cytarabine Injection BP Side Effects

Bone marrow suppression is the effect that governs how this drug is used. Counts fall, and the schedule is built around that rather than around convenience. Beyond it, approved labeling records:

• Blood counts: leukopenia, thrombocytopenia, anemia, and megaloblastic changes.
• Gastrointestinal: nausea, vomiting, diarrhea, abdominal pain and oral ulceration.
• Liver and general: hepatic dysfunction and fever.
• High-dose therapy: central nervous system, gastrointestinal and pulmonary toxicity, corneal toxicity and hemorrhagic conjunctivitis, and skin shedding with hair loss.
• Rare but serious: anaphylaxis, pancreatitis and tumor lysis syndrome.

One reaction carries the name of the drug itself and is worth knowing if you field calls from hospitals. Cytarabine syndrome appears roughly six to twelve hours after a dose, with fever, muscle and bone pain, a maculopapular rash, conjunctivitis, sometimes chest pain, and a general feeling of illness. Corticosteroids help, both to treat it and to prevent it, and an oncology team that expects it is far less likely to stop a course over it.

Cytarabine Injection BP Manufacturer

We work as a WHO GMP certified cytarabine injection BP supplier in India and fill Cytarabine Injection BP 100mg/ml on a cytotoxic filling line with containment, dedicated areas and operator protection applied from dispensing through to packing. An unpreserved cytotoxic solution leaves no room for error on sterility, so the cost of the product sits in filtration, filling, and release testing rather than in the drug itself.

Two kinds of buyers come to us for it. Either your oncology range covers solid tumors but has no leukemia product in it, or you want a cytarabine injection BP third party manufacturer who will put your artwork on the carton so you do not have to build a cytotoxic facility. We run both the same way. You confirm the pack, the artwork, and the market, and we schedule production against your volume. To start, tell us your volumes and the destination market.

Cytarabine Injection BP Price

The Cytarabine Injection BP Price in India is MRP 585 INR per vial for our TOROCYT-100 Injection, listed right now at 485 INR. The drug is a small part of that. Cytotoxic containment, a sterile unpreserved fill, and release testing carry the figure, and they cost the same whether the vial holds 100 mg or more.

Your order size moves the rest. The more vials you take, the lower the figure per unit, and a quantity built for a hospital tender will not price like a trial order. For price-related inquiries, contact our sales team with your monthly requirement and the destination market, and we will come back with current rates.

Frequently Asked Questions

Who are we allowed to supply this product to?

Cancer hospitals and institutions, against the prescription of a cancer specialist. That restriction is printed on the carton, so it travels with the product wherever you sell it. Plan your distribution around oncology institutions rather than general retail, and keep the documentation that shows where each consignment went.

Can this vial be given into the spine?

The carton on this pack is labeled for intravenous injection, so that is the route it is supplied for. Cytarabine as a molecule does appear with intrathecal and subcutaneous routes in approved labeling elsewhere, which is why the question comes up, but route follows the label of the product you actually hold. Check with us before you quote it for anything else.

Is there a preservative in the solution?

No. The carton states that it contains no antibacterial preservatives. The vial holds cytarabine in water for injection, nothing more, and it is a single-use presentation. Once it is broached for a patient, the remainder is discarded rather than held for a second dose.

What should we do if a vial looks cloudy or has particles in it?

Do not use it. The carton carries that caution directly, and visible particulate matter is a reason to quarantine the vial rather than filter it or warm it. Hold the batch, record the storage conditions it traveled under, and come back to us with the batch number.

Can we carry our own cytarabine injection BP brand name?

Yes. You can take it as TOROCYT-100 Injection, or under a brand you own with your artwork on the mono carton, through third-party supply or a PCD arrangement. A cytarabine injection BP contract manufacturer should be able to show you the quality release and the batch documentation before you commit, and we do that as a matter of course. The formulation and the line do not change. Only the name on the carton does.

Disclaimer: This page is written for pharmaceutical companies, distributors, PCD franchise partners and healthcare professionals. Cytarabine is a prescription-only cytotoxic product, to be supplied against demand from a cancer hospital or institution and against the prescription of a cancer specialist. The information here supports trade and supply decisions, makes no claim of cure or outcome, and does not replace advice from a qualified doctor.